MAPT and Alzheimer disease: Though TfRMAb-TNFR resulted in an innate immune response (TREM2-positive microglial clustering) towards the β-sheet-rich Aβ plaques in the 3xTg-AD mice, we did not see significant changes in tau phosphorylation with the treatment.